In the latest trading session, 0.78 million Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) shares changed hands as the company’s beta touched -0.12. With the company’s most recent per share price at $1.45 changed hands at -$0.12 or -7.96% at last look, the market valuation stands at $67.31M. RVPH’s current price is a discount, trading about -206.9% off its 52-week high of $4.45. The share price had its 52-week low at $0.60, which suggests the last value was 58.62% up since then.
Analysts gave the Reviva Pharmaceuticals Holdings Inc (RVPH) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended RVPH as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Reviva Pharmaceuticals Holdings Inc’s EPS for the current quarter is expected to be -0.22.
Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) trade information
Instantly RVPH was in red as seen in intraday trades today. With action -19.72%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -20.17%, with the 5-day performance at -19.72% in the red. However, in the 30-day time frame, Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) is -23.54% down.
Reviva Pharmaceuticals Holdings Inc (RVPH) estimates and forecasts
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
The 2025 estimates are for Reviva Pharmaceuticals Holdings Inc earnings to increase by 40.26%, but the outlook for the next 5-year period is at 20.47% per year.
Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH)’s Major holders
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 4.2659% or 1.03 million shares worth $1.31 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. With 700.44 shares estimated at $1.02 million under it, the former controlled 2.09% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.93% of the shares, roughly 312.3 shares worth around $0.45 million.
